Shortage of Contrast for Imaging Services

Because of a global shortage of iodinated contrast material (Omnipaque) caused by temporary overseas manufacturing disruptions, ChristianaCare is taking steps to preserve supply so that it remains available for the most time-sensitive and urgent patient needs. (Learn more in our frequently asked questions.)

Omnipaque contrast is the most widely used contrast material for CT scans and radiographic examinations at ChristianaCare facilities. It is also used for cardiac imaging and interventions, and in the GI lab, Surgicenter and other settings.

The shortage is expected to last several weeks, and likely into the summer months.

Hospitals and health care organizations worldwide are managing the effects of the shortage and the impact to patient care.

ChristianaCare is making every effort to meet the needs of patients who need this product in their procedures. We are working individually with physicians to prioritize those patients with the most urgent needs.

Wherever possible, we are using alternative contrast material and limiting its use to ensure adequate supplies for time sensitive and emergent exams. It is possible that some elective procedures that use this product will need to be delayed.

ChristianaCare will continue to look for options to minimize disruptions created by the shortage, as we serve our community as expert, caring partners in health.

Learn more in our frequently asked questions (FAQs).

COVID-19: Click here for what to expect at ChristianaCare during COVID-19

ChristianaCare

Shortage of Contrast for Imaging Services

Because of a global shortage of iodinated contrast material (Omnipaque) caused by temporary overseas manufacturing disruptions, ChristianaCare is taking steps to preserve supply so that it remains available for the most time-sensitive and urgent patient needs. (Learn more in our frequently asked questions.)

Omnipaque contrast is the most widely used contrast material for CT scans and radiographic examinations at ChristianaCare facilities. It is also used for cardiac imaging and interventions, and in the GI lab, Surgicenter and other settings.

The shortage is expected to last several weeks, and likely into the summer months.

Hospitals and health care organizations worldwide are managing the effects of the shortage and the impact to patient care.

ChristianaCare is making every effort to meet the needs of patients who need this product in their procedures. We are working individually with physicians to prioritize those patients with the most urgent needs.

Wherever possible, we are using alternative contrast material and limiting its use to ensure adequate supplies for time sensitive and emergent exams. It is possible that some elective procedures that use this product will need to be delayed.

ChristianaCare will continue to look for options to minimize disruptions created by the shortage, as we serve our community as expert, caring partners in health.

Learn more in our frequently asked questions (FAQs).

COVID-19: Click here for what to expect at ChristianaCare during COVID-19

Genetic Consultation and Risk Assessment

Cancer Genetic Risk Assessment Program

Research clearly shows a link between certain genes and cancer risks, including breast, colorectal, endometrial (uterine), melanoma, ovarian, pancreatic, prostate and thyroid cancers. The link is often strongest in families where:

  • Cancer is diagnosed before age 50.
  • Cancer shows up in more than one generation.
  • Individual family members have bilateral cancer (cancer in both the left and right breasts).
  • Cancer occurs in the less commonly affected gender (male breast cancer).
  • Several rare cancers (ovarian, pancreatic, sarcoma) occur in a family.

Knowing your personal risk based on your family health history may help you and your doctor prevent cancer or detect it early when it is most treatable.

Make an appointment today to complete your personal cancer risk assessment with a licensed genetic counselor. Call us at 302-623-4593, option 1, or toll-free at 1-800-811-8116.

Personal Cancer Risk Assessment

A personal cancer risk assessment begins with a detailed personal and family medical history. Our licensed counselors have years of expertise to help you:

  • Determine if you have an increased risk for a particular cancer.
  • Help you understand what it means to be at risk for a hereditary cancer (breast, colorectal, ovarian)
  • Discuss the benefits, risks and limitations of genetic testing.
  • Discuss ways you can decrease your risk for developing cancer through lifestyle changes, screening or surgical interventions.
  • Identify available clinical trials or research studies for which you may qualify.
  • Identify and refer you to specialists who can help you with follow-up medical or emotional support.